Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Beta Bionics (BBNX) Equity Ratio (2023 - 2026)

Beta Bionics' Equity Ratio history spans 4 years, with the latest figure at 0.89 for Q1 2026.

  • On a quarterly basis, Equity Ratio fell 4.0% to 0.89 in Q1 2026 year-over-year; TTM through Mar 2026 was 0.89, a 4.0% decrease, with the full-year FY2025 number at 0.87, up 153.36% from a year prior.
  • Equity Ratio hit 0.89 in Q1 2026 for Beta Bionics, up from 0.87 in the prior quarter.
  • Over the last five years, Equity Ratio for BBNX hit a ceiling of 0.93 in Q1 2025 and a floor of 1.85 in Q4 2023.
  • Historically, Equity Ratio has averaged 0.15 across 4 years, with a median of 0.89 in 2026.
  • Biggest five-year swings in Equity Ratio: soared 153.36% in 2025 and later fell 4.0% in 2026.
  • Tracing BBNX's Equity Ratio over 4 years: stood at 1.85 in 2023, then grew by 11.17% to 1.64 in 2024, then soared by 153.36% to 0.87 in 2025, then increased by 1.85% to 0.89 in 2026.
  • Business Quant data shows Equity Ratio for BBNX at 0.89 in Q1 2026, 0.87 in Q4 2025, and 0.89 in Q3 2025.